Recent CME Stock Price | CME Stock Predictions | |
$227.88 | +7.49% |
$244.94 |
Recent CME Analyst Ratings Breakdown, Making CME Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 6 | 7 | 7 | 7 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 9 | 8 | 8 | 8 |
Sell ratings: | 1 | 1 | 1 | 1 |
Strong sell ratings: | 2 | 2 | 2 | 2 |
Average rating: | 2.61 | 2.5 | 2.5 | 2.5 |
For the CME stock predictions from the analysts covering CME Group Inc, we have collected all of the individual CME stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 17 different analysts covering CME (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CME stock predictions may vary widely, another useful metric to consider is the median CME stock prediction, which represents the price at which half of the analysts
made CME stock predictions that were higher and half made CME stock predictions that were lower. This makes for a different take on the CME stock predictions out there, as compared to average or mean.
And that median across all the individual CME stock predictions was: $250.0 as of 2025-01-16.
The very highest of the CME stock predictions for one year price target was $275.0, while the very lowest of the CME stock predictions in the analyst group was
$190.0 (with a standard deviation of $21.798). Get the latest Zacks research report on CME — FREE
Find out: CME next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
GLRE Stock Predictions
ATVI Stock Predictions
CLSK Stock Predictions
SDC Stock Predictions
SPCE Stock Predictions
GRPN Stock Predictions
VXRT Stock Predictions
CLXT Stock Predictions
LSI Stock Predictions
|
CME Next Dividend Date » (Projection based upon history) CME Dividend Growth Rate » Quotes delayed 20 minutes |
Hold (2.39 out of 4) 4th percentile
(ranked lower than approx. 96% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |